These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34697822)

  • 21. Borrowing of information across patient subgroups in a basket trial based on distributional discrepancy.
    Zheng H; Wason JMS
    Biostatistics; 2022 Jan; 23(1):120-135. PubMed ID: 32380518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal Bayesian hierarchical model to accelerate the development of tissue-agnostic drugs and basket trials.
    Jiang L; Nie L; Yan F; Yuan Y
    Contemp Clin Trials; 2021 Aug; 107():106460. PubMed ID: 34098036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Bayesian basket trial design accounting for uncertainties of homogeneity and heterogeneity of treatment effect among subpopulations.
    Asano J; Hirakawa A
    Pharm Stat; 2020 Nov; 19(6):975-1000. PubMed ID: 32779393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials.
    Su L; Chen X; Zhang J; Yan F
    JCO Precis Oncol; 2022 Mar; 6():e2100394. PubMed ID: 35263169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing the efficiency of oncology basket trials using a Bayesian approach.
    Liu R; Liu Z; Ghadessi M; Vonk R
    Contemp Clin Trials; 2017 Dec; 63():67-72. PubMed ID: 28629993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. rBMA: A robust Bayesian Model Averaging Method for phase II basket trials based on informative mixture priors.
    Wang X; Wei W
    Contemp Clin Trials; 2024 May; 140():107505. PubMed ID: 38521384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bayesian Additive Regression Trees (BART) with covariate adjusted borrowing in subgroup analyses.
    Pan J; Bunn V; Hupf B; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):613-626. PubMed ID: 35737650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flexible Bayesian subgroup analysis in early and confirmatory trials.
    Bunn V; Liu R; Lin J; Lin J
    Contemp Clin Trials; 2020 Nov; 98():106149. PubMed ID: 32942055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses.
    Zhang J; Lin R; Chen X; Yan F
    Clin Trials; 2024 Jun; 21(3):308-321. PubMed ID: 38243401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New clinical trial design borrowing information across patient subgroups based on fusion-penalized regression models.
    Kerioui M; Iasonos A; Gönen M; Arfé A
    Stat Methods Med Res; 2024 Aug; ():9622802241267355. PubMed ID: 39158499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Bayesian basket trial design that borrows information across strata based on the similarity between the posterior distributions of the response probability.
    Fujikawa K; Teramukai S; Yokota I; Daimon T
    Biom J; 2020 Mar; 62(2):330-338. PubMed ID: 31608505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bayesian sample size determination in basket trials borrowing information between subsets.
    Zheng H; Grayling MJ; Mozgunov P; Jaki T; Wason JMS
    Biostatistics; 2023 Oct; 24(4):1000-1016. PubMed ID: 35993875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Bayesian latent class extension of naive Bayesian classifier and its application to the classification of gastric cancer patients.
    Gohari K; Kazemnejad A; Mohammadi M; Eskandari F; Saberi S; Esmaieli M; Sheidaei A
    BMC Med Res Methodol; 2023 Aug; 23(1):190. PubMed ID: 37605107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trials.
    Collier W; Haaland B; Inker LA; Heerspink HJL; Greene T
    BMC Med Res Methodol; 2024 Feb; 24(1):39. PubMed ID: 38365599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequentist analysis of basket trials with one-sample Mantel-Haenszel procedures.
    Hattori S; Morita S
    Stat Med; 2023 Nov; 42(26):4824-4849. PubMed ID: 37670577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trials.
    Berry SM; Broglio KR; Groshen S; Berry DA
    Clin Trials; 2013 Oct; 10(5):720-34. PubMed ID: 23983156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
    Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
    Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subgroup-specific dose finding for phase I-II trials using Bayesian clustering.
    Curtis A; Smith B; Chapple AG
    Stat Med; 2022 Jul; 41(16):3164-3179. PubMed ID: 35429178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Borrowing information across subgroups in phase II trials: is it useful?
    Freidlin B; Korn EL
    Clin Cancer Res; 2013 Mar; 19(6):1326-34. PubMed ID: 23303215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basket trials in oncology: a systematic review of practices and methods, comparative analysis of innovative methods, and an appraisal of a missed opportunity.
    Kasim A; Bean N; Hendriksen SJ; Chen TT; Zhou H; Psioda MA
    Front Oncol; 2023; 13():1266286. PubMed ID: 38033501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.